Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

11:33 EDT 27th April 2015 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 21,000+

Monday 27th April 2015

Researchers develop new model to investigate cancer’s earliest stages

Researchers at the Northwestern University have developed a computational model that enables to examine how emerging metastatic tumors interact with the immune system.

Astellas Launches CRESEMBA® (isavuconazonium sulfate) in the United States for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

NORTHBROOK, Ill., April 27, 2015 /PRNewswire/ -- Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis (also known as zygomycosis). These are life-threatening fungal infections predominantly occurring in immunocompromi...

JJ Smith Offers Free Webinar: Lose 2 Dress Sizes by Summer

WASHINGTON, April 27, 2015 /PRNewswire/ -- #1 New York Times best-selling author, nutritionist and certified weight loss expert and author of the mega hit, 10-Day Green Smoothie Cleanse, JJ Smith, is hosting a free webinar, Lose 2 Dress Sizes by Summer on Wednesday, April 29, 2015.  There is limited seating, so be sure to sign up if you're looking to jump-start your weight loss, improve your ...

AZ's Celgene tie-up 'will boost immuno-oncology business'

AstraZeneca (AZ) has forged an alliance with Celgene to accelerate the development of its checkpoint inhibitor MEDI4736 in blood cancers.The deal is one of two designed to bolster the potential of AZ's primary immuno-oncology asset MEDI4736, with AZ ...

Provectus Biopharmaceuticals to Present at Asia Biotech Invest 2015 Conference Wednesday, May 20, 2015, Hong Kong

Provectus Presentation Scheduled for 10 AM Local Time Conference at Sheraton Hotel and Towers, Hong Kong, May 19-21, 2015 Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),

Author Patty Blue Hayes to Debut Her New Book, “Wine, Sex and Suicide - My Near Death Divorce,” on Amazon.com

With the launch of her new book, “Wine, Sex and Suicide - My Near Death Divorce,” author and life coach Patty Blue Hayes reveals just how deadly divorce can be. LOS ANGELES (PRWEB) April 27, 2015 According to a study-based article titled, “Suicide and Divorce” by Jason Kohlmeyer dated May 16, 2012, divorced people are three times more likely to commit suicide than their married peers. The...

Edico Genome, in Collaboration with Researchers from Harvard and Stanford Universities, Speeds Analysis of Whole Genome Sequence with 300x Depth of Coverage Tenfold

SAN DIEGO, April 27, 2015 /PRNewswire/ -- Edico Genome today announced that collaborative data generated with biochemists and geneticists from Harvard and Stanford Universities showed the DRAGEN™ Bio-IT Processor sped analysis of a whole genome sequence with 300x depth of coverage by tenfold, generating results in approximately six hours compared to 60 hours with standard software. "P...

Proton partners international announces partnership with global leaders to equip UK's first proton beam therapy centres

Proton Partners International Limited, which is planning to build three Proton Beam Therapy cancer treatment centres in the UK, has announced the appointment of global partners to provide state of the art clinical equipment and innovative technology....

FDA approves ramucirumab for metastatic colorectal cancer

The US Food and Drug Administration has approved ramucirumab (Cyramza) for use in combination with FOLFIRI for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- ...

Fight The Fourth Leading Cause Of Cancer Death In The United States At PurpleStride Los Angeles

LOS ANGELES, April 27, 2015 /PRNewswire-USNewswire/-- When a person in the United States is diagnosed with pancreatic cancer they may learn any number of the following statistics – Pancreatic cancer is currently the fourth leading cause of cancer-related death in the United States and is anticipated to become the second by 2020 Pancreatic cancer is one of the nation's deadliest cancers, ...

Aratana Therapeutics Comments on ADXS31-164 (AT-014) Study Data Presented During Poster Session at the American Association for Cancer Research (AACR) Annual Meeting 2015

KANSAS CITY, Kan., April 27, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today provided commentary on clinical study data involving ADXS31-164 (AT-014) that was recently presented during a poster session at the American Asso...

INRFOOD Paving Way for Better, More Personalized Nutrition With Launch of Free Mobile App

DURHAM, N.C., April 27, 2015 /PRNewswire/ -- INRFOOD (http://www.inrfood.com/) is giving people more control of their nutrition, beginning with a better understanding of what goes into today's foods and how dietary decisions directly affect peoples' health and wellness. With its assortment of practical tools like calorie counting and ingredient analysis, the company's new, customizable free m...

Vermillion to Report First Quarter 2015 Financial Results and Host Investor Conference Call on May 11

AUSTIN, Texas, April 27, 2015 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, announced today it will report first quarter 2015 financial results after the market close on Monday, May 11, 2015, followed by an investor conference call and webcast at 4:30pm Eastern. Conference Call & Webcast: Monday, May 11, 2015 at 4:30pm Easter...

The Mesothelioma Victims Center Urges Victims to Call for Their Customized Treatment Options Report and Calls Attention to Emerging Science

WASHINGTON, April 27, 2015 /PRNewswire/ -- The Mesothelioma Victims Center is calling attention to a new medical breakthrough from the Memorial Sloan Kettering Cancer Center involving hunter cells treatments that could eliminate mesothelioma cancer cells in any diagnosed victim, and is urging current victims of this rare form of cancer to call them at 866-714-6466 for immediate info...

Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL

DOYLESTOWN, Pa., April 27, 2015 /PRNewswire/ -- Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced the presentation of preclinical antiviral data for its lead HBV core inhibitor candidate, NVR 3-778, at the 2015 annual meeting of the European Assoc...

VentiRx Pharmaceuticals Granted Orphan Drug Designation in the European Union For Motolimod in the Treatment of Ovarian Cancer

SEATTLE, April 27, 2015 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of novel Toll-like receptor 8 (TLR8) immunotherapies in the treatment of cancer, announced today that the European Commission (EC), acting on the positive recommendation from the European Medicines Agency (EMA) Committee for Orphan Medical Products (COMP), ha...

Celsion Corporation Announces Appointment of Harriet Shelare to Director, Communications

LAWRENCEVILLE, N.J., April 27, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the appointment of Harriet Shelare as Director, Communications effective immediately. Ms. Shelare is an independent counselor with more than 20 years' experience in healthcare public relations, including media relations, issues management and public edu...

Varian Unveils VitalBeam™ for Affordable Advanced Radiotherapy

PALO ALTO, Calif., April 27, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) last week unveiled a radiotherapy platform designed to offer clinics an affordable option for implementing advanced image-guided radiotherapy.  Varian's VitalBeam™ system is a new cost-effective technology package for offering high-quality, high-throughput radiation therapy, and for expanding clinic...

Senior and Stronger: Building Muscles to Reduce Age-Related Injury

BRENTWOOD, Tenn., April 27, 2015 /PRNewswire/ -- Most older people know the importance of aerobic activity. But fewer realize another type of exercise is crucial for preventing injuries and debility. Throughout May, Brookdale teams will visit seniors in their homes to introduce them to resistance training, necessary to offset age-related muscle loss that increases the risk of falling. The "Senior ...

Erlanger Health System to Install Omnicell Solutions for Medication Management

MOUNTAIN VIEW, Calif., April 27, 2015 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Erlanger Health System has selected Omnicell's medication management and workflow solutions to further the institution's goal of being an industry-leading health system.   The selection and integration of Omnicell technology will assist with not only patient safety but also operational e...

Rwanda Wants Investor for Multi-Million Dollar Cancer Facility, Reports KT Press

KIGALI, Rwanda, April 27, 2015 /PRNewswire/ -- Rwanda is looking for a potential investor to set up a cancer treatment facility, and help the country cut down the number of Rwandans traveling for the service abroad. The facility, worth $12 million includes radiotherapy, will provide cancer diagnosis, a service currently limited.  "We have received a few proposals. We still need more ...

Broga yoga for men - more macho, less mantra

NEW YORK (Reuters) - Men who crave the benefits of yoga but recoil at sharing the experience with a room full of women are turning to Broga, a rugged take on the 3,000-year-old practice of movement and breath.

5 million euros for medical innovation Dutch government invests in the pearls of previous research

The Dutch Ministry of Economic Affairs has granted 2.5 million euros to extend seven promising research projects aimed at medical innovation. The projects, which are focused at debilitating and life-threatening diseases such as breast cancer, prostat...

Altered bacteria may reduce inflammation and alleviate inflammatory bowel diseases

An imbalance of bacteria in the gut can cause inflammation, a driver of conditions such as colitis, Crohn’s disease and colon cancer. Now University of Florida Health scientists, in collaboration with researchers from North Carolina State Universit...

Gonorrhoea and syphilis in Norway in 2014

Reported cases of gonorrhea continue to increase in Norway, both among men who have sex with men (MSM) and among heterosexuals. The increase of gonorrhea among heterosexual women was particularly significant. Reported cases of syphilis in 2014 remain...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks